StockData
Surgery Partners, Inc. logo

Surgery Partners, Inc. (SGRY) stock

SGRYNasdaqServices-General Medical & Surgical Hospitals, NECFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 5/3011% above fair value
$26.96+0.11 (+0.41%)

Close on Nov 18, 2026Market cap $3.53BP/E –Yield –

Surgery Partners revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Surgery Partners's revenue for the twelve months ending Jun 30, 2026 was $3.37B, up 4.0% year over year. For fiscal 2025 it was $3.31B, up 6.2% from the year before. Over ten years it grew 23.4% a year on average. The highest annual figure on record is $3.31B in fiscal 2025.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$3.31B+6.2%
FY2024Dec 31, 2024$3.11B+13.5%
FY2023Dec 31, 2023$2.74B+8.0%
FY2022Dec 31, 2022$2.54B+14.1%
FY2021Dec 31, 2021$2.23B+19.6%
FY2020Dec 31, 2020$1.86B+1.6%
FY2019Dec 31, 2019$1.83B+3.4%
FY2018Dec 31, 2018$1.77B+54.7%
FY2016Dec 31, 2016$1.15B+19.3%
FY2015Dec 31, 2015$959.89M+138.0%
FY2014Dec 31, 2014$403.29M+41.7%
FY2013Dec 31, 2013$284.60M–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$848.90M+2.7%
Q1 FY2026Mar 31, 2026$810.90M+4.5%
Q4 FY2025Dec 31, 2025$885.00M+2.4%
Q3 FY2025Sep 30, 2025$821.50M+6.6%
Q2 FY2025Jun 30, 2025$826.20M+8.4%
Q1 FY2025Mar 31, 2025$776.00M+8.2%
Q4 FY2024Dec 31, 2024$864.40M+17.5%
Q3 FY2024Sep 30, 2024$770.40M+14.3%
Q2 FY2024Jun 30, 2024$762.10M+14.2%
Q1 FY2024Mar 31, 2024$717.40M+7.7%
Q4 FY2023Dec 31, 2023$735.40M+4.0%
Q3 FY2023Sep 30, 2023$674.10M+8.6%
Q2 FY2023Jun 30, 2023$667.60M+8.5%
Q1 FY2023Mar 31, 2023$666.20M+11.7%
Q4 FY2022Dec 31, 2022$707.10M+15.9%
Q3 FY2022Sep 30, 2022$620.60M+11.0%
Q2 FY2022Jun 30, 2022$615.40M+13.3%
Q1 FY2022Mar 31, 2022$596.20M+16.4%
Q4 FY2021Dec 31, 2021$610.20M+11.3%
Q3 FY2021Sep 30, 2021$559.20M+12.7%
Q2 FY2021Jun 30, 2021$543.30M+45.0%
Q1 FY2021Mar 31, 2021$512.40M+16.2%
Q4 FY2020Dec 31, 2020$548.30M+6.0%
Q3 FY2020Sep 30, 2020$496.10M+9.8%
Q2 FY2020Jun 30, 2020$374.70M-15.9%
Q1 FY2020Mar 31, 2020$441.00M+5.8%
Q4 FY2019Dec 31, 2019$517.20M+5.3%
Q3 FY2019Sep 30, 2019$452.00M+4.5%
Q2 FY2019Jun 30, 2019$445.40M+2.0%
Q1 FY2019Mar 31, 2019$416.80M+1.3%
Q4 FY2018Dec 31, 2018$491.20M+6.7%
Q3 FY2018Sep 30, 2018$432.40M+50.0%
Q2 FY2018Jun 30, 2018$436.60M+52.6%
Q1 FY2018Mar 31, 2018$411.30M+34.4%
Q4 FY2017Dec 31, 2017$460.35M+62.8%
Q2 FY2017Jun 30, 2017$288.35M–
Q1 FY2017Mar 31, 2017$286.18M–
Q4 FY2016Dec 31, 2016$306.00M–
Q3 FY2016Sep 30, 2016$282.68M–

More Surgery Partners figures

See a number that looks wrong?